从一项肿瘤学去中心化临床试验失败中吸取的教训。
Lessons learned from an unsuccessful decentralized clinical trial in Oncology.
作者信息
Valachis Antonis, Lindman Henrik
机构信息
Department of Oncology, Faculty of Medicine and Health, Örebro University Hospital, Örebro University, Örebro, Sweden.
Department of Immunology, Genetics and Pathology, Experimental and Clinical Oncology; Clinical Oncology, Faculty of Medicine, Uppsala University Hospital, Uppsala, Sweden.
出版信息
NPJ Digit Med. 2024 Aug 13;7(1):211. doi: 10.1038/s41746-024-01214-5.
Abstract
Decentralized clinical trials have gained in popularity over the last years due to their advantages related to broadening recruitment strategies and resource saving possibilities. As more clinical trials adopt decentralized strategies, it is essential to share the knowledge about both successful and unsuccessful efforts in the research community. In the present commentary, we explore potential reasons that led to early termination of a decentralized clinical trial in Oncology.
摘要
在过去几年中，去中心化临床试验因其在拓展招募策略和节省资源方面的优势而越来越受欢迎。随着越来越多的临床试验采用去中心化策略，在研究界分享成功和失败经验的相关知识至关重要。在本评论中，我们探讨了导致一项肿瘤学去中心化临床试验提前终止的潜在原因。
相似文献
1
Lessons learned from an unsuccessful decentralized clinical trial in Oncology.从一项肿瘤学去中心化临床试验失败中吸取的教训。
NPJ Digit Med. 2024 Aug 13;7(1):211. doi: 10.1038/s41746-024-01214-5.
2
Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned.试验创新网络中的去中心化临床试验：价值、策略及经验教训
J Clin Transl Sci. 2023 Jul 25;7(1):e170. doi: 10.1017/cts.2023.597. eCollection 2023.
3
From a decentralized clinical trial to a decentralized and clinical-trial-in-a-box platform: Towards patient-centric and equitable trials.从分散式临床试验到分散式一体化临床试验平台：迈向以患者为中心的公平试验。
J Clin Transl Sci. 2023 Oct 9;7(1):e236. doi: 10.1017/cts.2023.629. eCollection 2023.
4
Secondary use of patient data within decentralized studies using the example of rare diseases in Germany: A data scientist's exploration of process and lessons learned.以德国罕见病为例，探讨分散式研究中患者数据的二次利用：一位数据科学家对流程及经验教训的探索。
Digit Health. 2024 Aug 10;10:20552076241265219. doi: 10.1177/20552076241265219. eCollection 2024 Jan-Dec.
5
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.国家脑肿瘤学会创新脑肿瘤临床试验圆桌研讨会报告：借鉴 COVID-19 经验。
Neuro Oncol. 2021 Aug 2;23(8):1252-1260. doi: 10.1093/neuonc/noab082.
6
Evaluation of a decentralized investigational drug service pharmacist in a cancer clinical trial infusion unit.评估癌症临床试验输液单元中分散的研究药物服务药剂师。
J Oncol Pharm Pract. 2024 Oct;30(7):1200-1206. doi: 10.1177/10781552231207854. Epub 2023 Oct 17.
7
Navigating Cancer Care in the COVID-19 Era.在新冠疫情时代的癌症护理
Cancer Discov. 2022 Feb;12(2):283. doi: 10.1158/2159-8290.CD-ND2021-0116. Epub 2021 Dec 9.
8
Implementation challenges and lessons learned from the STREAM clinical trial-a survey of trial sites.从 STREAM 临床试验中得到的实施挑战和经验教训-对试验点的调查。
Trials. 2023 Jan 23;24(1):51. doi: 10.1186/s13063-023-07068-8.
9
Lessons learned from a pharmacy practice model change at an academic medical center.从学术医疗中心的药房实践模式转变中吸取的经验教训。
Am J Health Syst Pharm. 2010 Nov 1;67(21):1862-9. doi: 10.2146/ajhp100210.
10
Remote Monitoring and Data Collection for Decentralized Clinical Trials.去中心化临床试验的远程监测和数据收集。
JAMA Netw Open. 2024 Apr 1;7(4):e246228. doi: 10.1001/jamanetworkopen.2024.6228.
引用本文的文献
1
Integrating mHealth Innovations into Decentralized Oncology Trials.将移动健康创新融入去中心化肿瘤学试验。
J Med Syst. 2025 Aug 8;49(1):103. doi: 10.1007/s10916-025-02233-9.
本文引用的文献
1
A systematic review of methods used to conduct decentralised clinical trials.系统评价去中心化临床试验中使用的方法。
Br J Clin Pharmacol. 2022 Jun;88(6):2843-2862. doi: 10.1111/bcp.15205. Epub 2022 Jan 27.
2
, , and Regarding Telemedicine Among Swedish Primary Care Physicians: A Qualitative Study.瑞典初级保健医生对远程医疗的看法：一项定性研究
Int J Gen Med. 2021 Dec 1;14:9237-9246. doi: 10.2147/IJGM.S334782. eCollection 2021.
3
Trust, medical expertise and humaneness: A qualitative study on people with cancer' satisfaction with medical care.信任、医学专业知识和人道精神：一项关于癌症患者对医疗服务满意度的定性研究。
Health Expect. 2021 Apr;24(2):317-326. doi: 10.1111/hex.13171. Epub 2021 Feb 2.
4
Digitizing clinical trials.临床试验数字化。
NPJ Digit Med. 2020 Jul 31;3:101. doi: 10.1038/s41746-020-0302-y. eCollection 2020.
5
Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer.在 HR 阳性晚期乳腺癌患者中，PI3K 抑制剂阿培利司联合氟维司群的随机 III 期 SOLAR-1 研究中关键不良事件的时间进程和管理。
Ann Oncol. 2020 Aug;31(8):1001-1010. doi: 10.1016/j.annonc.2020.05.001. Epub 2020 May 13.
6
Advancing the Use of Mobile Technologies in Clinical Trials: Recommendations from the Clinical Trials Transformation Initiative.推进移动技术在临床试验中的应用：临床试验转化倡议的建议
Digit Biomark. 2019 Nov 6;3(3):145-154. doi: 10.1159/000503957. eCollection 2019 Sep-Dec.
7
Digital clinical trials: creating a vision for the future.数字化临床试验：展望未来
NPJ Digit Med. 2019 Dec 12;2:126. doi: 10.1038/s41746-019-0203-0. eCollection 2019.
8
The role of patient-physician relationship on health-related quality of life and pain in cancer patients.医患关系对癌症患者健康相关生活质量和疼痛的影响。
Support Care Cancer. 2020 Jun;28(6):2615-2626. doi: 10.1007/s00520-019-05070-y. Epub 2019 Oct 16.
9
Alpelisib for -Mutated, Hormone Receptor-Positive Advanced Breast Cancer.阿培利司治疗 - 突变型、激素受体阳性晚期乳腺癌。
N Engl J Med. 2019 May 16;380(20):1929-1940. doi: 10.1056/NEJMoa1813904.
10
Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.系统评价和荟萃分析癌症临床试验参与的结构、临床以及医生和患者障碍的程度。
J Natl Cancer Inst. 2019 Mar 1;111(3):245-255. doi: 10.1093/jnci/djy221.
Zotero 插件